{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:46:21Z","timestamp":1791913581343,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011703","name":"Yorkshire Cancer Research","doi-asserted-by":"publisher","award":["L399"],"award-info":[{"award-number":["L399"]}],"id":[{"id":"10.13039\/100011703","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.lungcan.2021.10.004","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T09:13:55Z","timestamp":1635153235000},"page":"71-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Quality of life after VATS lung resection and SABR for early-stage non-small cell lung cancer: A longitudinal study"],"prefix":"10.1016","volume":"162","author":[{"given":"Cecilia","family":"Pompili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Absolom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Holch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Callister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnathan","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Brunelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Franks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Velikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2021.10.004_b0005","unstructured":"UK CR. Cancer Statistics Key Facts 2017 [Available from: http:\/\/www.cancerresearchuk.org\/cancer-info\/cancerstats\/keyfacts\/Allcancerscombined\/."},{"key":"10.1016\/j.lungcan.2021.10.004_b0010","doi-asserted-by":"crossref","unstructured":"Detterbeck FC, Boffa DJ, Kim AW, Tanoue LT. The Eighth Edition Lung Cancer Stage Classification. Chest. 2017;151(1):193-203.","DOI":"10.1016\/j.chest.2016.10.010"},{"issue":"2","key":"10.1016\/j.lungcan.2021.10.004_b0015","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/ejcts\/ezv154","article-title":"Video-assisted thoracoscopic surgery versus open lobectomy for primary non-small-cell lung cancer: a propensity-matched analysis of outcome from the European Society of Thoracic Surgeon database","volume":"49","author":"Falcoz","year":"2016","journal-title":"Eur. J. Cardio-thorac. Surg."},{"issue":"1","key":"10.1016\/j.lungcan.2021.10.004_b0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1183\/09031936.00184308","article-title":"ERS\/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)","volume":"34","author":"Brunelli","year":"2009","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lungcan.2021.10.004_b0025","unstructured":"Physicians. RCo. National Lung Cancer Audit Annual Report 2019. 2019."},{"issue":"4","key":"10.1016\/j.lungcan.2021.10.004_b0030","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1470-2045(18)30896-9","article-title":"Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial","volume":"20","author":"Ball","year":"2019","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2021.10.004_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2016.08.015","article-title":"SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC","volume":"121","author":"Nyman","year":"2016","journal-title":"Radiother. Oncol."},{"issue":"7","key":"10.1016\/j.lungcan.2021.10.004_b0040","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1097\/JTO.0b013e318252cfef","article-title":"Patient-reported quality of life after stereotactic ablative radiotherapy for early-stage lung cancer","volume":"7","author":"Lagerwaard","year":"2012","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2021.10.004_b0045","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijrobp.2018.01.064","article-title":"Stereotactic ablative radiation therapy versus surgery in early lung cancer: a meta-analysis of propensity score studies","volume":"101","author":"Chen","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"8","key":"10.1016\/j.lungcan.2021.10.004_b0050","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.21037\/jtd.2017.07.35","article-title":"Patient reported outcomes following video assisted thoracoscopic (VATS) resection or stereotactic ablative body radiotherapy (SABR) for treatment of non-small cell lung cancer: protocol for an observational pilot study (LiLAC)","volume":"9","author":"Pompili","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.lungcan.2021.10.004_b0055","doi-asserted-by":"crossref","unstructured":"Pompili C, Boele F, Absolom K, Holch P, Clayton B, Smyllie E, et al. Patients' views of routine quality of life assessment following a diagnosis of early-stage non-small celllung cancer. Interact. Cardiovasc. Thorac. Surg. 2020;31(3):324\u2013330.","DOI":"10.1093\/icvts\/ivaa123"},{"issue":"Suppl. 3","key":"10.1016\/j.lungcan.2021.10.004_b0060","first-page":"iii1","article-title":"Guidelines on the radical management of patients with lung cancer","volume":"65","author":"Lim","year":"2010","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.lungcan.2021.10.004_b0065","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"issue":"24","key":"10.1016\/j.lungcan.2021.10.004_b0070","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1002\/cncr.29682","article-title":"Use of the lung cancer-specific Quality of Life Questionnaire EORTC QLQ-LC13 in clinical trials: A systematic review of the literature 20 years after its development","volume":"121","author":"Koller","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2021.10.004_b0075","article-title":"on behalf of the EORTC Quality of Life Group. The EORTC QLQ-C30 Scoring Manual","author":"Fayers","year":"2001","journal-title":"3 rd Edition"},{"key":"10.1016\/j.lungcan.2021.10.004_b0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jclinepi.2015.08.007","article-title":"Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust","volume":"69","author":"Giesinger","year":"2016","journal-title":"J. Clin. Epidemiol."},{"issue":"5","key":"10.1016\/j.lungcan.2021.10.004_b0085","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF00451727","article-title":"Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer","volume":"3","author":"Osoba","year":"1994","journal-title":"Qual. Life Res."},{"issue":"5","key":"10.1016\/j.lungcan.2021.10.004_b0090","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","article-title":"Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation","volume":"41","author":"Norman","year":"2003","journal-title":"Med. Care"},{"issue":"9596","key":"10.1016\/j.lungcan.2021.10.004_b0095","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet (London, England)"},{"issue":"8","key":"10.1016\/j.lungcan.2021.10.004_b0100","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jama.2013.879","article-title":"Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension","volume":"309","author":"Calvert","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.lungcan.2021.10.004_b0105","doi-asserted-by":"crossref","unstructured":"Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin. Radiat. Oncol. 2003;13(3):176\u2013181.","DOI":"10.1016\/S1053-4296(03)00031-6"},{"issue":"1","key":"10.1016\/j.lungcan.2021.10.004_b0110","doi-asserted-by":"crossref","first-page":"154","DOI":"10.21037\/jtd.2018.12.30","article-title":"Changes in quality of life after surgery or radiotherapy in early-stage lung cancer","volume":"11","author":"Schwartz","year":"2019","journal-title":"J. Thorac. Dis."},{"issue":"12","key":"10.1016\/j.lungcan.2021.10.004_b0115","doi-asserted-by":"crossref","first-page":"7055","DOI":"10.21037\/jtd.2018.11.89","article-title":"Are quality of life outcomes comparable following stereotactic radiotherapy and minimally invasive surgery for stage I lung cancer patients?","volume":"10","author":"Pompili","year":"2018","journal-title":"J. Thorac. Dis."},{"issue":"4","key":"10.1016\/j.lungcan.2021.10.004_b0120","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1245\/s10434-019-08090-4","article-title":"Impact on health-related quality of life of video-assisted thoracoscopic surgery for lung cancer","volume":"27","author":"Avery","year":"2020","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.lungcan.2021.10.004_b0125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejca.2018.11.024","article-title":"General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States","volume":"107","author":"Nolte","year":"2019","journal-title":"Eur. J. Cancer (Oxford England)"},{"issue":"11","key":"10.1016\/j.lungcan.2021.10.004_b0130","first-page":"767","article-title":"Quality of life as a clinical trial endpoint: determining the appropriate interval for repeated assessments in patients with advanced lung cancer","volume":"12","author":"Hollen","year":"2004","journal-title":"Support. Care Cancer"},{"issue":"12","key":"10.1016\/j.lungcan.2021.10.004_b0135","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/JTO.0b013e31815cff64","article-title":"A systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung cancer","volume":"2","author":"Tanvetyanon","year":"2007","journal-title":"J. Thorac. Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2021.10.004_b0140","doi-asserted-by":"crossref","first-page":"2000118","DOI":"10.1183\/13993003.00118-2020","article-title":"SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection","volume":"56","author":"Franks","year":"2020","journal-title":"Eur. Respir. J."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500221005742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500221005742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:56:57Z","timestamp":1791910617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500221005742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":28,"alternative-id":["S0169500221005742"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2021.10.004","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of life after VATS lung resection and SABR for early-stage non-small cell lung cancer: A longitudinal study","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2021.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}